Literature DB >> 9839443

Vascular endothelial growth factor.

I Zachary1.   

Abstract

Vascular endothelial growth factor (VEGF) plays a crucial role in angiogenesis in development, in cancer and in other important diseases. VEGF regulates multiple endothelial cell functions including mitogenesis, permeability, vascular tone, and the production of vasoactive molecules. VEGF is related to several polypeptides which may have different and overlapping functions. The synthesis of VEGF is regulated by hypoxia-mediated control of gene transcription, alternative mRNA splicing and proteolytic processing. The diverse biological activities of VEGF are mediated through at least two receptor protein tyrosine kinases, KDR/Flk-1 and Flt-1. Because of VEGF's central importance for pathophysiological angiogenesis, the development of antagonists for VEGF in the treatment of cancer, and the use of VEGF therapeutically in cardiovascular diseases are now the focus of major research efforts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9839443     DOI: 10.1016/s1357-2725(98)00082-x

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  15 in total

Review 1.  Therapeutic targets for hypoxia-elicited pathways.

Authors:  C T Taylor; S P Colgan
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

2.  Exposure to ethanol during the last trimester of pregnancy alters the maturation and immunity of the fetal lung.

Authors:  Tatjana Lazic; Fatoumata B Sow; Albert Van Geelen; David K Meyerholz; Jack M Gallup; Mark R Ackermann
Journal:  Alcohol       Date:  2010-12-15       Impact factor: 2.405

Review 3.  Angiogenesis in epithelian ovarian cancer.

Authors:  E S Bamberger; C W Perrett
Journal:  Mol Pathol       Date:  2002-12

4.  The inhibitory effects of rh-endostatin (YH-16) in combination with radiotherapy on lung adenocarcinoma A549 in mice and the underlying mechanisms.

Authors:  Huita Wu; Jie Deng; Shiying Yu; Xin Wang; Yuan Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-02-14

5.  The combined effect of recombinant human epidermal growth factor and erythropoietin on full-thickness wound healing in diabetic rat model.

Authors:  Joon Pio Hong; Sung Woo Park
Journal:  Int Wound J       Date:  2012-10-19       Impact factor: 3.315

6.  MAIDS resistance-associated gene expression patterns in secondary lymphoid organs.

Authors:  Suprawee Tepsuporn; Jedediah N Horwitt; George W Cobb; Sharon A Stranford
Journal:  Immunogenetics       Date:  2008-07-09       Impact factor: 2.846

7.  Induction of a potential paracrine angiogenic loop between human THP-1 macrophages and human microvascular endothelial cells during Bartonella henselae infection.

Authors:  Sandra I Resto-Ruiz; Michael Schmiederer; Debra Sweger; Catherine Newton; Thomas W Klein; Herman Friedman; Burt E Anderson
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

8.  Improvement of a long random skin flap survival by application of vascular endothelial growth factor in various ways of local administration in a rat model.

Authors:  Spyridon A Vourtsis; Apostolos E Papalois; George D Agrogiannis; Petros K Spyriounis; Efstratios Patsouris; Mihai Ionac
Journal:  Indian J Plast Surg       Date:  2012-01

9.  Inhibition of retinal neovascularization by siRNA targeting VEGF(165).

Authors:  Xiao-bo Xia; Si-qi Xiong; Wei-tao Song; Jie Luo; Yu-ke Wang; Rong-rong Zhou
Journal:  Mol Vis       Date:  2008-10-30       Impact factor: 2.367

10.  The adverse effect of selective cyclooxygenase-2 inhibitor on random skin flap survival in rats.

Authors:  Haiyong Ren; Dingsheng Lin; Zhenyu Mou; Pu Dong
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.